breast-cancer-research.com/content
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Breast Cancer Research
official impact factor 5.25
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Breast Cancer Research
  • Subscriptions

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most popular RSS
  • Issues
  • Supplements
  • Article collections

HER2 therapy

Edited by Mark Pegram

Collection published: 6 November 2006

Last updated: 4 June 2007


Review   Free Highly Accessed

HER-2 therapy. HER-2/neu diagnostics in breast cancer

Walter P Carney, Kim Leitzel, Suhail Ali, Rainer Neumann, Allan Lipton Breast Cancer Research 2007, 9:207 (4 June 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review   Free

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors

Neil Spector, Wenle Xia, Iman El-Hariry, Yossi Yarden, Sarah Bacus Breast Cancer Research 2007, 9:205 (2 March 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review   Free

HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks

Ralf Landgraf Breast Cancer Research 2007, 9:202 (22 January 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review   Free Highly Accessed

HER2 therapy: Molecular mechanisms of trastuzumab resistance

Rita Nahta, Francisco J Esteva Breast Cancer Research 2006, 8:215 (6 November 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.